HER2 Mutation-Related Tumors research hub

A Phase 1/1b Study of IAM1363 in HER2 Cancers

This study is testing a new medicine called IAM1363 for advanced cancers with a specific change called HER2. It aims to find a safe and effective dose, including for breast, lung, and stomach cancers that have spread to the brain.